THE XMRV INFO CENTER
Info
Testing, Treatment and Transmission
Blogs and Articles
- Clinical Director Dr. Deckoff-Jones Talks On the WPI’s Clinic
- Dr. Mikovits in Sweden: New Findings in XMRV
- Retrovirology Publishes 5 Papers on Contamination
- A Draw at the Blood Working Group
- XMRV at the Tipping Point
- What’s Next For XMRV?
- Batter Up! The XMRV/MLV Debate Continues
- Pathogen Ace To Lead Major New NIH XMRV Study
- Lots of Questions at the XMRV Int Workshop…and One Big Answer?
- Pathogen Ace To Lead Major NIH XMRV Study
- FOUR Viruses? The Alter XMRV Paper Arrives
- Opening the Door on a New Era: the WPI Opens
- The Best XMRV Study Underway? Dr. Singh Talks!
- Where’s the Beef? the WPI, XMRV and the NIH
- A New Kind of XMRV? Dr. Mikovits and Dr. Racaniello on XMRV (July)
- Who’s in and Who’s Out on the International Workshop on XMRV (July)
- CFIDS Association Webinar on XMRV with Dr. Bateman and Dr. Racaniello (July)
- How Not to Find XMRV? CDC Study Published (July ’10)
- XMRV Confirmation Imminent? (June 22 ’10)
- Dr. Mikovits at the IACFS/ME (May ’10)
- WPI Throws the Gauntlet Down (April ’10)
- XMRV’s Big Test Has Begun (Apr)
- Light in the Darkness: Good News Ahead for XMRV? (3/26)
- Muddy Waters (3/23)
- XMRV – Check, Check, Check? (3/20/10)?
- Second UK Study fails to find XMRV (2/10)
- XMRV Files: A Review (3/10)
The Science
- Overview
- The First Retrovirus
- Imperial College Replication Attempt!
- Hope and Caution
- Proving XMRV – The Next Steps
- The Puppet Master
ME/CFS Professionals Talk on XMRV
- Dr. Mikovits Prohealth Lecture: Part I / Part II / Part III / (Jan ’10)
- Dr. Bell’s Tustin, Ca Lecture Part I / Part II (Jan ’10) –
- Dr. Klimas on XMRV Pt I (Oct 09)
- Dr. Klimas on XMRV Pt II (Oct 09)
- Dr. Peterson at the CFSAC (Oct 09)
- Dr. Coffin at the CFSAC (Oct 09)
- Dr. Coffin/Peterson Q & A at the CFSAC(Oct 09)
Powered by 
Translate
The discovery of the XMRV retrovirus in most chronic fatigue syndrome (ME/CFS) patients could be a demarcating point in the history of this illness. The publication of the study in Science, the most prestigious scientific journal in the world, by a stellar cast of researchers from the National Cancer Institute, the Cleveland Clinic and the Whittemore Peterson Institute prompted a flood of stories across the major media outlets and scientific publications including Nature, Scientific American, the New York Times, (two articles), NPR, Fox News, LA Times, etc.
Amid concerns that the blood supply was contaminated the NIH officials announced they’d already held a conference on the issue. The Whittemore Peterson Institute rapidly conferred a new name for what it believes are a cadre of XMRV diseases they’re choosing to call XAND (X Associated Neuroimmune Diseases).
Questions were quickly raised concerning prevalence, transmission, testing, treatment, etc. Much is still unknown about this new finding with news coming in almost daily.
The Latest
- Clinical Director Dr. Deckoff-Jones Talks On the WPI’s Clinic
- Dr. Mikovits- the Santa Rosa Lecture
- Dr. Mikovits In Sweden: New Findings on XMRV
- Researchers on XMRV: the Twix podcast with Dr. Racaniello
- A ‘Draw’ at the Blood Working Group”
- XMRV at the Tipping Point: A Tale of Two Conferences
- Batter Up! The XMRV/MLV Debate Continues
- Pathogen Ace To Lead Major New NIH XMRV Study
Phoenix Rising has many resources on XMRV.
Check out the Phoenix Rising XMRV Buzz page for up-to-date information on the latest news and events.
Check out Treatment and Testingsections, transcriptions of talks, theResources section, an XMRV Studiespage and much more are available.
The ‘Bringing the Heat’ Blog and theFront Page section of the Phoenix Rising Forums frequently feature articles on XMRV. Of course thePhoenix Rising Forums are the place to go to discuss XMRV.
Please post comments/suggestions to me using the contact box on the above left top of the page or at phoenixcfs@gmail.com.
The Phoenix Rising website is compiled by a layman. It is not a substitute for a physician and is for informational uses only. It does not present complete information on this drug. Please discuss any treatments in these pages with your physician.